Shuijie Li Selected Research

Shuijie Li Research Topics

Disease

9	Neoplasms (Cancer) 05/2024 - 12/2011
4	Neuroblastoma 01/2021 - 01/2016
2	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2021
2	Heart Failure 12/2023 - 11/2023
2	Inflammation (Inflammations) 01/2023 - 01/2022
2	von Hippel-Lindau Disease (von Hippel Lindau Disease) 10/2022 - 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 05/2024
1	Cardiomyopathies (Cardiomyopathy) 01/2024
1	Cardiotoxicity 01/2024
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2023
1	Hypertrophy 12/2023
1	Infarction (Infarctions) 12/2023
1	Myocardial Infarction 12/2023
1	Starvation 11/2023
1	Atherosclerotic Plaque (Atheroma) 11/2023
1	Atherosclerosis 11/2023
1	Tuberous Sclerosis (Bourneville's Disease) 11/2023
1	Acute Kidney Injury (Acute Renal Failure) 01/2023
1	Ureteral Obstruction 01/2022
1	Renal Insufficiency (Renal Failure) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Adenocarcinoma 01/2021
1	Aneuploidy (Aneuploid) 01/2021
1	Carcinogenesis 01/2021
1	Adenoviridae Infections (Adenovirus Infections) 10/2020
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020
1	Islet cell tumor syndrome 01/2019
1	Pheochromocytoma 01/2019
1	Weight Loss (Weight Reduction) 06/2016
1	Body Weight (Weight, Body) 06/2016

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 12/2023 - 01/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2024 - 01/2021
2	CollagenIBA 12/2023 - 01/2022
2	Oxygen (Dioxygen)IBA 10/2022 - 01/2022
2	Adenosine Triphosphatases (ATPase)IBA 02/2012 - 12/2011
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 05/2024
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 05/2024
1	Dacarbazine (DIC)FDA LinkGeneric 01/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024
1	IronIBA 01/2024
1	Transcription Factors (Transcription Factor)IBA 12/2023
1	p38 Mitogen-Activated Protein KinasesIBA 12/2023
1	dapagliflozinIBA 11/2023
1	Glucose (Dextrose)FDA LinkGeneric 11/2023
1	SodiumIBA 11/2023
1	Apolipoproteins E (ApoE)IBA 11/2023
1	Amino Acids FDA Link 11/2023
1	TOR Serine-Threonine KinasesIBA 11/2023
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2023
1	trans-sodium crocetinate (crocetin)IBA 11/2023
1	Long Noncoding RNAIBA 11/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2023
1	ras ProteinsIBA 11/2023
1	Interleukin-15 (Interleukin 15)IBA 01/2023
1	dihydromyricetinIBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	Scavenger Receptors (Scavenger Receptor)IBA 11/2022
1	AMP-Activated Protein KinasesIBA 01/2022
1	NitritesIBA 01/2022
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2022
1	NitratesIBA 01/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	N- (2,4- difluorophenyl)- N'- (4- ((6,7- dimethoxy- 4- quinolyl)oxy)- 2- fluorophenyl)ureaIBA 01/2021
1	RNA Splicing FactorsIBA 01/2021
1	rho GTPase-activating proteinIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	GTP Phosphohydrolases (GTPases)IBA 01/2021
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	RotenoneIBA 10/2020
1	Imatinib Mesylate (Gleevec)FDA Link 01/2020
1	Mixed Function Oxygenases (Monooxygenases)IBA 01/2019
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	Differentiation AntigensIBA 01/2017
1	RetinoidsIBA 01/2017
1	ResveratrolIBA 06/2016
1	Insulin (Novolin)FDA Link 06/2016
1	LipidsIBA 06/2016
1	CalcineurinIBA 01/2016

Therapy/Procedure

3	Therapeutics 05/2024 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2019 - 01/2017
1	Immunotherapy 11/2022